市場調査レポート

商品コード

1588501

エソテリック検査市場規模、シェア、成長分析、技術別、タイプ別、検体別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Esoteric Testing Market Size, Share, Growth Analysis, By Technology, By Type, By Specimen, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年11月02日
発行: SkyQuest
ページ情報: 英文 206 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

エソテリック検査の世界市場規模は、2022年に301億米ドルと評価され、2023年の326億9,000万米ドルから2031年には632億5,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは8.60％で成長する見通しです。

がん診断薬市場は、がん罹患率が上昇する中、早期発見やより安全な診断方法に対する需要の高まりにより、大きな成長を遂げています。米国国立生物工学情報センター（NCBI）は、米国におけるがんの診断件数は約195万件、関連死亡者数は60万9,820人という憂慮すべき統計を発表しており、効果的な診断ソリューションが緊急に必要であることを強調しています。さらに、独立した検査室における高度な潜伏検査技術の出現は、市場拡大をさらに推進する態勢を整えています。リアルタイムポリメラーゼ連鎖反応や次世代シークエンシングのような革新は、状況を再形成し、外科医と患者の両方におけるエソテリック診断への関心の高まりにつながっています。従来の血液検査や尿検査とは異なり、潜血検査は高度な技術を備えた専門的な検査室環境を必要とするため、より正確で効果的な結果が得られます。このような検査はコストが高くなる可能性があるが、臨床や調査の場で的を絞った洞察を提供する能力により、貴重なものとなります。市場が発展するにつれ、技術の進歩と高度な診断検査への嗜好の高まりが融合し、革新的ながん診断薬への需要が今後数年間で大幅に増加することが確実視されています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Labcorp（US）
Quest Diagnostics（US）
OPKO Health, Inc.（US）
H.U. Group Holdings, Inc.（Japan）
Sonic Healthcare Limited（Australia）
Mayo Foundation for Medical Education and Research（MFMER）（US）
Eurofins Scientific（Luxembourg）
Stanford Health Care（US）
Kindstar Globalgene Technology, Inc.（China）
Georgia Esoteric & Molecular Laboratory, LLC（US）
ACM Global Laboratories（US）
NMS Labs（US）
Healthquest Esoterics（US）
Cerba Xpert（France）
Leolabs, Inc.（US）
Flow Health（US）
Invitae Corporation（US）
Myriad Genetics, Inc.（US）
Arup Laboratories（US）
Fulgent Genetics（US）
Biomontr Labs（US）
Labgenomics（South Korea）

Product Code: SQMIG35A2910

Global Esoteric Testing Market size was valued at USD 30.1 billion in 2022 and is poised to grow from USD 32.69 billion in 2023 to USD 63.25 billion by 2031, growing at a CAGR of 8.60% during the forecast period (2024-2031).

The market for cancer diagnostics is experiencing significant growth, driven by a heightened demand for early detection and safer diagnostic methods amid rising cancer incidence rates. The National Center for Biotechnology Information (NCBI) provides alarming statistics, estimating approximately 1.95 million cancer diagnoses and 609,820 related deaths in the United States, underscoring the urgent need for effective diagnostic solutions. Additionally, the emergence of advanced latent testing technologies in independent laboratories is poised to further propel market expansion. Innovations such as real-time polymerase chain reaction and next-generation sequencing are reshaping the landscape, leading to increased interest in esoteric diagnostics among both surgeons and patients. Unlike traditional blood or urine tests, occult tests require specialized laboratory environments equipped with advanced technology, providing more precise and effective results. While these tests can entail higher costs, their ability to deliver targeted insights in clinical or research settings makes them invaluable. As the market evolves, the convergence of technological advancements and a growing preference for advanced diagnostic testing is likely to dominate the landscape, ensuring that the demand for innovative cancer diagnostics rises significantly in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Esoteric Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Esoteric Testing Market Segmental Analysis

Global Esoteric Testing Market is segmented by Technology, Type, Specimen, End User, and Region. Based on Technology, the market is segmented into Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay Real-Time PCR, DNA Sequencing and Next-Generation Sequencing, Flow Cytometry, Chromatography and Mass Spectrometry, and Other Technologies. Based on Type, the market is segmented into Oncology Testing, Autoimmune Disease Testing, Infectious Disease Testing, Endocrinology Testing, Genetic Testing, Neurology Testing, Toxicology and Drug Monitoring Testing, Other Types of Testing. Based on Specimen, the market is segmented into Blood, Serum, and Plasma, Urine, and Other Specimens. Based on End User, the market is segmented into Independent and Reference Laboratories, and Hospital-Based Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Esoteric Testing Market

The global esoteric testing market is significantly driven by the alarming increase in chronic diseases, including cancer, cardiovascular diseases, and diabetes, which necessitate advanced diagnostic methodologies. With the growing prevalence of these conditions, there is an urgent demand for specialized tests capable of detecting biomarkers, genetic mutations, and nuanced molecular alterations that traditional diagnostic methods may overlook. This heightened focus on early diagnosis and personalized treatment regimens underscores the critical role of esoteric testing in contemporary healthcare. Consequently, healthcare providers are increasingly adopting these sophisticated testing approaches, thereby propelling the growth of the esoteric testing market on a global scale.

Restraints in the Global Esoteric Testing Market

A significant market restraint for the Global Esoteric Testing market is the prohibitive cost of specialized diagnostic methods. These esoteric tests necessitate advanced technology, specialized reagents, and highly trained personnel, resulting in elevated operational expenses. Such financial barriers restrict access to these tests in resource-limited settings, particularly in developing regions where budget constraints are prevalent. Furthermore, the necessity for extensive laboratory infrastructure further exacerbates the situation, leading to inequitable distribution of esoteric testing services. Consequently, the high costs associated with these diagnostic services may hinder their adoption, limiting the market's growth potential and accessibility in broader healthcare contexts.

Market Trends of the Global Esoteric Testing Market

In the Global Esoteric Testing market, a significant trend is emerging towards personalized and precise treatment methodologies, driven by advancements in genomics and molecular diagnostics. Healthcare providers increasingly recognize the value of tailoring medications to individual patient profiles, enhancing treatment efficacy and safety. This paradigm shift is fueled by the integration of occult analysis, which offers profound insights into genetic variations and biomarkers specific to each patient. As a result, customized therapeutic regimens are becoming the norm, significantly impacting patient outcomes and fostering a more targeted approach to healthcare. Consequently, the market is poised for robust growth, reflecting these transformative changes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Patent Analysis
Customer & Buying Criteria Analysis

Esoteric Testing Market by Technology

Market Overview
Chemiluminescence Immunoassay
Enzyme-Linked Immunosorbent Assay
Real-Time PCR
DNA Sequencing and Next-Generation Sequencing
Flow Cytometry
Chromatography and Mass Spectrometry
Other Technologies

Esoteric Testing Market by Type

Market Overview
Oncology Testing
Autoimmune Disease Testing
Infectious Disease Testing
Endocrinology Testing
Genetic Testing
Neurology Testing
Toxicology And Drug Monitoring Testing
Other Types of Testing

Esoteric Testing Market by Specimen

Market Overview
Blood, Serum, and Plasma
Urine
Other Specimens

Esoteric Testing Market by End User

Market Overview
Independent and Reference Laboratories
Hospital-Based Laboratories

Esoteric Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Labcorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OPKO Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H.U. Group Holdings, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mayo Foundation for Medical Education and Research (MFMER) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stanford Health Care (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kindstar Globalgene Technology, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Georgia Esoteric & Molecular Laboratory, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NMS Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Healthquest Esoterics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerba Xpert (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leolabs, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flow Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arup Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fulgent Genetics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomontr Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labgenomics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

エソテリック検査市場規模、シェア、成長分析、技術別、タイプ別、検体別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Esoteric Testing Market Size, Share, Growth Analysis, By Technology, By Type, By Specimen, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

エソテリック検査市場：技術別

エソテリック検査市場：タイプ別

エソテリック検査市場：検体別

エソテリック検査市場：エンドユーザー別

エソテリック検査市場：地域別